Tag: coronavirus

We remain cognizant of the impact that COVID-19 has had on our insureds, their staff and their loved ones. We recognize the rising Delta variant and its impact upon communities with a high unvaccinated population and continue to battle vaccine hesitancy and misinformation.

COVID-19 has forced substantial shifts in how dentists, and many professionals, work every day. Over the past year, dentists have had a chance to reexamine the way they practice and determine if those habits still make sense in the face of a threat like COVID-19. In a recent article, Dr. Lauren Patton reflects on the teachings of 2020. Read about the lessons she learned during the pandemic.

A recent study published in the Journal of Dental Research marks the first COVID-19 testing survey of asymptomatic patients in a dental setting. The paper showed the potential for dental offices to be viable and powerful locations for public health surveillance. The authors of the study identified dental offices as a good location for research for several reasons.

The oral cavity is an important site for COVID-19 infection, a recent study in Nature Medicine found. The researchers set out to better understand the “involvement of the oral cavity” in COVID-19. What they found has implications for the growing understanding of COVID-19 and the continued global effort to reduce the transmission of the virus.

Vulnerabilities related to the pandemic are amplifying the threat of cyberattacks on health networks. Understanding key IoMT-associated risks can help mitigate risk and minimize the potential scope of damage.

The U.S. Food and Drug Administration issued an emergency use authorization for simultaneous administration of monoclonal antibodies bamlanivimab and etesevimab to treat COVID-19 patients who meet specific criteria.

Guidance published by Oregon Health & Science University scientists outlines a preoperative protocol for surgical care teams to evaluate the readiness of previously COVID-positive patients for elective procedures.

From risk management tips and FAQs to publications and the MLMIC blog, we are committed to supporting today’s dental professionals. Visit our website and follow us on social media to take advantage of all we have to offer.

The U.S. Food and Drug Administration is evaluating the potential impact of SARS-CoV-2 viral mutations on authorized molecular tests.

An alert issued by The Joint Commission highlights the critical importance of supporting clinicians bearing the weight of the COVID-19 crisis.